Testicular Function and Hormone Status in Patients with Malignant Germ Tumors Germ Tumors Before and after Treatment

  • S. D. Fosså
Part of the Ettore Majorana International Science Series book series (EMISS, volume 8)


Testicular cancer is predominantly a malignancy of young men. The majority of these patients can be cured today, so that maintenance of fertility has become an important issue. It is, therefore, of interest to evaluate to what extent the various treatment regimes may influence fertility and hormone status in these patients.


Follicle Stimulate Hormone Testicular Cancer Hormone Status Testicular Function Follicle Stimulate Hormone Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M. J. Peckham, A. Barrett, T. J. McElwain, and W. F. Hendry, Combined management of malignant teratoma of the testis,The Lancet, August II, (1979).Google Scholar
  2. 2.
    O. Klepp, R. Klepp, H. Host, G. Asbjornsen, K. Talle, and A. E. Stenwig, Combination chemotherapy of germ cell tumors of the testis with vincristine, adriamycin, cyclophosphamide, actino-mycin D and medroxyprogesterone acetate,Cancer, 40:638(1977).CrossRefGoogle Scholar
  3. 3.
    S. D. Fosså, O. Klepp, S. Ous, H. H. Lien, A. E. Stenwig, T. Abyholm, and O. Kaalhus, Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I, Europ.Urol., submitted (1983).Google Scholar
  4. 4.
    O. Klepp, S. D. Fosså, S. Ous, H. Lien, J. T. Stenwig, V. Abeler, G. Eliassen, and H. Host, Multi-modality treatment of advanced malignant germ cell tumors in males, I: Experience with cis-platinum-based combination chemotherapy, Scand.J. Urol.Neprhrol., in press (1983).Google Scholar
  5. 5.
    S. D. Fosså, O. Klepp, S. Ous, H. Lien, J. T. Stenwig, V. Abeler, G. Eliassen, and H. H6st, Multi-modality treatment in males with advanced malignant germ cell tumors, II: Experience with surgery and radiotherapy following cis-platinum-based chemotherapy, Scand.J.Urol.Nephrol., submitted (1983).Google Scholar
  6. 6.
    S. D. Fosså, O. Klepp, K. Molne, and A. Aakvaag: Testicular function after unilateral orchiectomy for cancer and before further treatment,Int.J.Andrology, 5:179–184 (1982).CrossRefGoogle Scholar
  7. 7.
    J. G. Berthelsen and N. E. Skakkebaek, Gonadal function in men with testis cancer,Fertility and sterility, 39:68–75 (1983).Google Scholar
  8. 8.
    B. P. Setchell, S. J. Main, and R. V. Davies, Effect of ligation of the efferent fucts of the testis on gonadotrophins and testosterone in rats,J.Endocrin., 72:13–14 (1977).Google Scholar
  9. 9.
    J. H. Lynch and W. C. Maxted, Use of ephidrine in post-lymphadectomy ejaculatory failure: A case report,J.Urol., 129, 139 (1983).Google Scholar
  10. 10.
    E. W. Hahn, S. M. Feingold, L. Simpson, and M. Batata, Recovery from aspermia induced by low-dose radiation in seminoma patients, Cancer 50: 337–340 (1982).CrossRefGoogle Scholar
  11. 11.
    S. D. Fosså O. Klepp, A. Aakvaag, and K. Molne, Testicular function after combined chemotherapy for metastatic testicular cancer,Int.J.Andrology, 3:59–65(1980).CrossRefGoogle Scholar
  12. 12.
    J. Donohue, R. Drasga, S. Williams, L. Einhorn, D. Patel, and E. Stevens: Gonadal function after chemotherapy in testicular cancer patients, The XIX Int.Congress of the Societe Internationale d’Urologie, San Francisco, September 173:5–10 (1982).Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • S. D. Fosså
    • 1
  1. 1.The Norwegian Radium HospitalOsloNorway

Personalised recommendations